Tris(dibenzylideneacetone)dipalladium(0)

CAS : 51364-51-3

Ref. 3D-FT37707

Informations sur le produit

• Nom: Tris(dibenzylideneacetone)dipalladium(0)
• Synonymes: 1,4-Pentadien-3-one, 1,5-diphenyl-, palladium complex, (E,E)-, Palladium, tris[μ-[(1,2-η:4,5-η)-1,5-diphenyl-1,4-pentadien-3-one]]di-, (all-E)-, Pd2(DBA)3, Pd₂(DBA)₃, Tris(dibenzylideneacetone)dipalladium, Tris(dibenzylideneacetonyl)bis-palladium, Tris[(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]dipalladium, Tris[dibenzylideneacetone]dipalladium (DBA palladium), Tris[μ-[(1,2-η:4,5-η)-(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]]dipalladium, tris[μ-[(1,2-η:4,5-η)-(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]]dipalladium [Pd2(dba)3], tris[μ-[(1,2-η:4,5-η)-(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]]dipalladium [Pd₂(dba)₃], Palladium, tris[μ-[(1,2-η:4,5-η)-(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]]di-

Description

Tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)) is a monoclonal antibody that is used to treat infectious diseases. The metal complex binds to the fatty acid and inhibits the synthesis of membrane lipids, which leads to an inhibition of virus replication. Tris(dibenzylideneacetone)dipalladium(0) has been shown to have potent antitumor activity in animal models, with cytotoxic effects on mutant melanoma cells and hydrochloric acid. This drug also has potent pro-apoptotic properties, inducing apoptosis by binding to pro-apoptotic proteins. Tris(dibenzylideneacetone)dipalladium(0) has been shown to be a potent inhibitor of x-ray crystal structures at high temperatures, where it competes with water for the labile hydrogen atoms on the surface of hydroxyl groups.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 915.72 g/mol
• Formule: C₁₇H₁₄O·Pd₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Purple Powder